Brenneman DE - Search Results

1

VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death.

Brenneman DE, Hauser J, Spong CY, Phillips TM, Pert CB, Ruff M. Brenneman DE, et al. Brain Res. 1999 Aug 14;838(1-2):27-36. doi: 10.1016/s0006-8993(99)01644-3. Brain Res. 1999. PMID: 10446313

2

Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity.

Brenneman DE, Hauser JM, Spong C, Phillips TM. Brenneman DE, et al. Neuropeptides. 2002 Aug;36(4):271-80. doi: 10.1016/s0143-4179(02)00045-8. Neuropeptides. 2002. PMID: 12372701

3

Potent gp120-like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals is blocked by peptide T.

Buzy J, Brenneman DE, Pert CB, Martin A, Salazar A, Ruff MR. Buzy J, et al. Among authors: brenneman de. Brain Res. 1992 Dec 11;598(1-2):10-8. doi: 10.1016/0006-8993(92)90161-2. Brain Res. 1992. PMID: 1486472

4

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB. Brenneman DE, et al. Nature. 1988 Oct 13;335(6191):639-42. doi: 10.1038/335639a0. Nature. 1988. PMID: 2845276

5

Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism.

Brenneman DE, Hauser J, Phillips TM, Davidson A, Bassan M, Gozes I. Brenneman DE, et al. Ann N Y Acad Sci. 1999;897:17-26. doi: 10.1111/j.1749-6632.1999.tb07875.x. Ann N Y Acad Sci. 1999. PMID: 10676432 Review.

6

Chemokines released from astroglia by vasoactive intestinal peptide. Mechanism of neuroprotection from HIV envelope protein toxicity.

Brenneman DE, Hauser J, Spong CY, Phillips TM. Brenneman DE, et al. Ann N Y Acad Sci. 2000;921:109-14. doi: 10.1111/j.1749-6632.2000.tb06956.x. Ann N Y Acad Sci. 2000. PMID: 11193813

7

Complex array of cytokines released by vasoactive intestinal peptide.

Brenneman DE, Phillips TM, Hauser J, Hill JM, Spong CY, Gozes I. Brenneman DE, et al. Neuropeptides. 2003 Apr;37(2):111-9. doi: 10.1016/s0143-4179(03)00022-2. Neuropeptides. 2003. PMID: 12747943

8

Protective peptides that are orally active and mechanistically nonchiral.

Brenneman DE, Spong CY, Hauser JM, Abebe D, Pinhasov A, Golian T, Gozes I. Brenneman DE, et al. J Pharmacol Exp Ther. 2004 Jun;309(3):1190-7. doi: 10.1124/jpet.103.063891. Epub 2004 Mar 8. J Pharmacol Exp Ther. 2004. PMID: 15007105

9

Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model.

Spong CY, Auth J, Vink J, Goodwin K, Abebe DT, Hill JM, Brenneman DE. Spong CY, et al. Among authors: brenneman de. Regul Pept. 2002 Oct 15;108(2-3):143-7. doi: 10.1016/s0167-0115(02)00104-0. Regul Pept. 2002. PMID: 12220738

10

Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist.

Glowa JR, Panlilio LV, Brenneman DE, Gozes I, Fridkin M, Hill JM. Glowa JR, et al. Among authors: brenneman de. Brain Res. 1992 Jan 20;570(1-2):49-53. doi: 10.1016/0006-8993(92)90562-n. Brain Res. 1992. PMID: 1617429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters